ES2160102T3 - Tratamiento del eritema provocado por uv. - Google Patents

Tratamiento del eritema provocado por uv.

Info

Publication number
ES2160102T3
ES2160102T3 ES93901140T ES93901140T ES2160102T3 ES 2160102 T3 ES2160102 T3 ES 2160102T3 ES 93901140 T ES93901140 T ES 93901140T ES 93901140 T ES93901140 T ES 93901140T ES 2160102 T3 ES2160102 T3 ES 2160102T3
Authority
ES
Spain
Prior art keywords
treatment
eritema
caused
induced skin
sunburn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93901140T
Other languages
English (en)
Inventor
Nicholas V Dr Perricone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2160102T3 publication Critical patent/ES2160102T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
  • Medicinal Preparation (AREA)

Abstract

METODO PARA EL TRATAMIENTO TERAPEUTICO O LA PREVENCION DE LOS DAÑOS CUTANEOS PRODUCIDOS POR RADIACION, ESPECIALMENTE LA PRODUCIDA POR RAYOS ULTRAVIOLETA (P.E., QUEMADURAS SOLARES), EN EL CUAL SE APLICA DE FORMA TOPICA UN ACIDO ALFA-HIDROXIDO O DERIVADO DEL MISMO EN LAS AREAS CUTANEAS AFECTADAS. SIENDO EL ACIDO GLICOLICO LA VERSION PREFERIDA.
ES93901140T 1992-09-11 1992-12-21 Tratamiento del eritema provocado por uv. Expired - Lifetime ES2160102T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94393592A 1992-09-11 1992-09-11

Publications (1)

Publication Number Publication Date
ES2160102T3 true ES2160102T3 (es) 2001-11-01

Family

ID=25480516

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93901140T Expired - Lifetime ES2160102T3 (es) 1992-09-11 1992-12-21 Tratamiento del eritema provocado por uv.

Country Status (5)

Country Link
EP (1) EP0751760B1 (es)
AT (1) ATE203395T1 (es)
DE (1) DE69231968T2 (es)
ES (1) ES2160102T3 (es)
WO (1) WO1994006405A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9608807A (pt) * 1995-05-26 1999-02-17 Unilever Nv Processo para melhorar cosmeticamente a pele humana através de um regime de tratamento e produto para regime de tratamento da pele
JPH11505811A (ja) * 1995-05-26 1999-05-25 ユニリーバー・ナームローゼ・ベンノートシヤープ 皮膚損傷を予防し、矯正するための化粧品
US6531116B1 (en) 1996-06-25 2003-03-11 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Treatment regime for skin
US6417226B1 (en) * 2000-12-12 2002-07-09 Nicholas V. Perricone Skin whiteners containing hydroxytetronic acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246261A (en) * 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
EP0245669B1 (de) * 1986-05-14 1993-12-01 Medopharm Arzneimittelwerk Dr. Zillich GmbH & Co. Pharmazeutisches Präparat zur Verhütung der Schädigung lebender Zellen durch freie Radikale, beziehungsweise zur Erhöhung der Wirksamkeit von organischen Schwefelverbindungen und Verfahren zur Erhöhung der Lebensdauer isolierter Organe
GB8620896D0 (en) * 1986-08-29 1986-10-08 Unilever Plc Cosmetic composition
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
LU86844A1 (fr) * 1987-04-13 1988-12-13 Oreal Utilisation a titre de produit cosmetique d'un complexe cuivrique de l'acide 3,5-diisopropyl salicylique et compositions cosmetiques pour la protection de l'epiderme humain contre le rayonnement uv contenant ce compose
US4847071A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
GB9010525D0 (en) * 1990-05-10 1990-07-04 Unilever Plc Cosmetic composition
JP2564690B2 (ja) * 1990-06-14 1996-12-18 三省製薬 株式会社 メラニン生成抑制外用剤
EP0508324B1 (en) * 1991-04-10 1999-03-17 Ruey J. Dr. Yu Use of cosmetic compositions comprising 2-hydrocarboxylic acids and related compounds for alleviating signs of nail changes

Also Published As

Publication number Publication date
EP0751760B1 (en) 2001-07-25
EP0751760A1 (en) 1997-01-08
WO1994006405A1 (en) 1994-03-31
DE69231968D1 (de) 2001-08-30
EP0751760A4 (en) 1996-11-07
DE69231968T2 (de) 2001-12-20
ATE203395T1 (de) 2001-08-15

Similar Documents

Publication Publication Date Title
NO962568L (no) Anvendelse av PLA2 inhibitorer som behandling for Alzheimers sykdom
DE68915900D1 (de) Angiogenese hemmendes Mittel.
BR9611479A (pt) Acidos alfa-iminoidroxâmicos e carboxílicos N-substituídos cíclicos e heterocíclicos
ATE332687T1 (de) Liponsäure in topischen mittel
DK0690851T3 (da) Guanidin-derivater, som er anvendelige til behandling
DK0725794T3 (da) Human monocyt-kemoattraktant protein-1 (MCP-1) derivater
DE60022756D1 (de) Hautpflegezusammensetzung
DK1030836T3 (da) Hydroxam- og carboxylsyrederivater der har MMP- og TNF-inhiberende aktivitet
ATE253932T1 (de) Verwendung von erythropoietin oder erythropoietin-derivaten zur behandlung von cerebralen ischämien
ATE182137T1 (de) Peptidylderivate als inhibitoren von metalloproteinase
ES2038609T3 (es) 4,5-dihidroisoxazol, 3,5 disustituido como inhibidores de transglutaminasa.
DK0396184T3 (da) Anvendelse af ketoconazol og et retinoid til behandling af acne vulgaris
ATE410158T1 (de) Fulvinsäure und deren verwendung in der behandlung von viralen infektionen
DE69212254D1 (de) Haarpflegemittel
DE69512589D1 (de) Behandlung von durch Talgdrüse verursachten Erkrankungen mit Inhibitoren der Acyl CoA Cholesterin Acyltransferase
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
DE3683333D1 (de) Mittel zur behandlung von akne vulgaris und deren herstellung.
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
ES2196313T3 (es) Utilizacion de inhibidores de la actividad del acido retinoico para el tratamiento de pieles sensibles y/o los daños agudos inducidos por las radiaciones uv.
ATE251631T1 (de) Dipohosphonsäuresalze für die behandlung von osteoporose
DE69231968D1 (de) Behandlung eines durch uv-strahlung verursachten erythems
ES2134184T3 (es) Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica.
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
ATE140922T1 (de) 3- oder 4-glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches mittel
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 751760

Country of ref document: ES